Your browser doesn't support javascript.
loading
BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency.
Afzali, Behdad; Grönholm, Juha; Vandrovcova, Jana; O'Brien, Charlotte; Sun, Hong-Wei; Vanderleyden, Ine; Davis, Fred P; Khoder, Ahmad; Zhang, Yu; Hegazy, Ahmed N; Villarino, Alejandro V; Palmer, Ira W; Kaufman, Joshua; Watts, Norman R; Kazemian, Majid; Kamenyeva, Olena; Keith, Julia; Sayed, Anwar; Kasperaviciute, Dalia; Mueller, Michael; Hughes, Jason D; Fuss, Ivan J; Sadiyah, Mohammed F; Montgomery-Recht, Kim; McElwee, Joshua; Restifo, Nicholas P; Strober, Warren; Linterman, Michelle A; Wingfield, Paul T; Uhlig, Holm H; Roychoudhuri, Rahul; Aitman, Timothy J; Kelleher, Peter; Lenardo, Michael J; O'Shea, John J; Cooper, Nichola; Laurence, Arian D J.
Afiliação
  • Afzali B; Lymphocyte Cell Biology Section (Molecular Immunology and Inflammation Branch), Biodata Mining and Discovery Section and Protein Expression Laboratory, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Grönholm J; MRC Centre for Transplantation, King's College London, London, UK.
  • Vandrovcova J; Molecular Development of the Immune System Section, NIAID Clinical Genomics Program, Biological Imaging Section (Research Technologies Branch) and Mucosal Immunity Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • O'Brien C; Molecular Neuroscience, Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Sun HW; Department of Medicine, Imperial College London, London, UK.
  • Vanderleyden I; Department of Medicine, Imperial College London, London, UK.
  • Davis FP; Lymphocyte Cell Biology Section (Molecular Immunology and Inflammation Branch), Biodata Mining and Discovery Section and Protein Expression Laboratory, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Khoder A; Laboratory of Lymphocyte Signaling and Development, Babraham Institute, Cambridge, UK.
  • Zhang Y; Lymphocyte Cell Biology Section (Molecular Immunology and Inflammation Branch), Biodata Mining and Discovery Section and Protein Expression Laboratory, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Hegazy AN; Department of Medicine, Imperial College London, London, UK.
  • Villarino AV; Molecular Development of the Immune System Section, NIAID Clinical Genomics Program, Biological Imaging Section (Research Technologies Branch) and Mucosal Immunity Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Palmer IW; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, UK.
  • Kaufman J; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Watts NR; Lymphocyte Cell Biology Section (Molecular Immunology and Inflammation Branch), Biodata Mining and Discovery Section and Protein Expression Laboratory, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Kazemian M; Lymphocyte Cell Biology Section (Molecular Immunology and Inflammation Branch), Biodata Mining and Discovery Section and Protein Expression Laboratory, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Kamenyeva O; Lymphocyte Cell Biology Section (Molecular Immunology and Inflammation Branch), Biodata Mining and Discovery Section and Protein Expression Laboratory, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Keith J; Lymphocyte Cell Biology Section (Molecular Immunology and Inflammation Branch), Biodata Mining and Discovery Section and Protein Expression Laboratory, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Sayed A; Department of Biochemistry and Department of Computer Science, Purdue University, West Lafayette, Indiana, USA.
  • Kasperaviciute D; Molecular Development of the Immune System Section, NIAID Clinical Genomics Program, Biological Imaging Section (Research Technologies Branch) and Mucosal Immunity Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Mueller M; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, UK.
  • Hughes JD; Department of Medicine, Imperial College London, London, UK.
  • Fuss IJ; Imperial BRC Genomics Facility, Hammersmith Hospital, London, UK.
  • Sadiyah MF; Imperial BRC Genomics Facility, Hammersmith Hospital, London, UK.
  • Montgomery-Recht K; Merck Research Laboratories, Merck &Co. Inc., Boston, Massachusetts, USA.
  • McElwee J; Molecular Development of the Immune System Section, NIAID Clinical Genomics Program, Biological Imaging Section (Research Technologies Branch) and Mucosal Immunity Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Restifo NP; Laboratory of Lymphocyte Signaling and Development, Babraham Institute, Cambridge, UK.
  • Strober W; Clinical Research Directorate/CMRP, Leidos Biomedical Research Inc., NCI at Frederick, Frederick, Maryland, USA.
  • Linterman MA; Merck Research Laboratories, Merck &Co. Inc., Boston, Massachusetts, USA.
  • Wingfield PT; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Uhlig HH; Molecular Development of the Immune System Section, NIAID Clinical Genomics Program, Biological Imaging Section (Research Technologies Branch) and Mucosal Immunity Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Roychoudhuri R; Laboratory of Lymphocyte Signaling and Development, Babraham Institute, Cambridge, UK.
  • Aitman TJ; Lymphocyte Cell Biology Section (Molecular Immunology and Inflammation Branch), Biodata Mining and Discovery Section and Protein Expression Laboratory, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Kelleher P; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, UK.
  • Lenardo MJ; Department of Paediatrics, University of Oxford, Oxford, UK.
  • O'Shea JJ; Laboratory of Lymphocyte Signaling and Development, Babraham Institute, Cambridge, UK.
  • Cooper N; Department of Medicine, Imperial College London, London, UK.
  • Laurence ADJ; Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Nat Immunol ; 18(7): 813-823, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28530713
ABSTRACT
The transcriptional programs that guide lymphocyte differentiation depend on the precise expression and timing of transcription factors (TFs). The TF BACH2 is essential for T and B lymphocytes and is associated with an archetypal super-enhancer (SE). Single-nucleotide variants in the BACH2 locus are associated with several autoimmune diseases, but BACH2 mutations that cause Mendelian monogenic primary immunodeficiency have not previously been identified. Here we describe a syndrome of BACH2-related immunodeficiency and autoimmunity (BRIDA) that results from BACH2 haploinsufficiency. Affected subjects had lymphocyte-maturation defects that caused immunoglobulin deficiency and intestinal inflammation. The mutations disrupted protein stability by interfering with homodimerization or by causing aggregation. We observed analogous lymphocyte defects in Bach2-heterozygous mice. More generally, we observed that genes that cause monogenic haploinsufficient diseases were substantially enriched for TFs and SE architecture. These findings reveal a previously unrecognized feature of SE architecture in Mendelian diseases of immunity heterozygous mutations in SE-regulated genes identified by whole-exome/genome sequencing may have greater significance than previously recognized.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Fatores de Transcrição de Zíper de Leucina Básica / Síndromes de Imunodeficiência Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Fatores de Transcrição de Zíper de Leucina Básica / Síndromes de Imunodeficiência Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article